Paid Bipolar Disorder Clinical Trials
Bipolar disorder clinical trials enrolling. Access new mood stabilizers and treatments. Compensation up to $3,000. Studies for bipolar I and II.
Compensation
$1,500 - $3,000
Duration
12-52 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 18-65 years
- Diagnosis of bipolar I or II disorder (DSM-5 criteria)
- Current mood episode (manic, depressed, or mixed) or stable for maintenance studies
- YMRS or MADRS score within study-specified range
- No current psychotic features (unless study-specific)
- Stable doses of permitted concomitant medications
Who May Not Qualify
- Rapid cycling (4+ episodes per year)
- Current substance use disorder
- Active suicidal ideation with intent
- Recent ECT treatment
- Treatment-resistant bipolar disorder
Frequently Asked Questions
What bipolar treatments are being studied?
+
Studies include new mood stabilizers, atypical antipsychotics, novel mechanisms for bipolar depression, and long-acting formulations. Both acute treatment and maintenance/prevention studies are available.
Are there separate studies for different mood episodes?
+
Yes, studies may specifically target manic episodes, depressive episodes, or maintenance (prevention of future episodes). Eligibility depends on your current clinical status.
How is mood monitored during the study?
+
Mood is assessed regularly using standardized rating scales (YMRS for mania, MADRS for depression). You may also complete daily or weekly mood diaries.
Can I continue my current mood medications?
+
Requirements vary by study. Some trials require discontinuation of current mood stabilizers, while others allow stable background therapy. Safety is carefully monitored during any medication changes.